Nutex Health Inc. (NASDAQ:NUTX) Receives $317.50 Average Target Price from Analysts

Nutex Health Inc. (NASDAQ:NUTX) has earned an average recommendation of “Buy” from the five research firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, three have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $317.50.

Several equities research analysts recently weighed in on the company. B Riley restated a “buy” rating on shares of Nutex Health in a research note on Friday, September 4th. Zacks Research upgraded shares of Nutex Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, August 24th. Wall Street Zen cut shares of Nutex Health from a “buy” rating to a “hold” rating in a report on Saturday, September 5th. Lake Street Capital restated a “buy” rating and set a $310.00 price objective (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. Finally, B. Riley Financial upped their target price on shares of Nutex Health from $290.00 to $325.00 and gave the company a “buy” rating in a report on Friday, September 4th.

Nutex Health Stock Up 0.9%

Nutex Health stock opened at $217.32 on Monday. The stock has a market cap of $1.49 billion, a PE ratio of 8.53 and a beta of 0.28. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96. The stock’s fifty day moving average is $178.46 and its two-hundred day moving average is $142.58. Nutex Health has a 1-year low of $83.99 and a 1-year high of $224.28.

Nutex Health (NASDAQ:NUTX) last released its quarterly earnings data on Thursday, August 6th. The company reported $9.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.95 by $4.43. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%.The business had revenue of $210.75 million during the quarter, compared to analysts’ expectations of $215.03 million. On average, sell-side analysts expect that Nutex Health will post 27.58 EPS for the current fiscal year.

Institutional Investors Weigh In On Nutex Health

Institutional investors and hedge funds have recently bought and sold shares of the stock. Kilter Group LLC acquired a new position in Nutex Health in the second quarter valued at $27,000. Islay Capital Management LLC acquired a new stake in shares of Nutex Health during the fourth quarter worth about $34,000. Allworth Financial LP purchased a new stake in shares of Nutex Health in the 2nd quarter valued at about $35,000. EverSource Wealth Advisors LLC purchased a new stake in shares of Nutex Health in the 1st quarter valued at about $83,000. Finally, Mcguire Capital Advisors Inc. acquired a new stake in shares of Nutex Health in the 4th quarter valued at about $165,000. 5.32% of the stock is owned by hedge funds and other institutional investors.

About Nutex Health

Nutex Health Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, outpatient facilities and physician practices. The company focuses on delivering emergency, inpatient and outpatient care through community-based healthcare facilities, including micro-hospitals designed to provide essential hospital services in convenient local settings.

Its services may include emergency medicine, primary care, specialty care, diagnostic testing, imaging, laboratory services and other ancillary healthcare offerings.